Mechanisms of disease: Mechanisms of thrombus formation

[1] CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism [J]. NATURE MEDICINE, 2002, 8 (03) : 247 - 252

[2] Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis [J]. NATURE MEDICINE, 2001, 7 (02) : 215 - 221

[3] [Anonymous], 1986, Lancet, V1, P397

[4] EXPRESSION OF TISSUE FACTOR PROCOAGULANT ACTIVITY - REGULATION BY CYTOSOLIC CALCIUM [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) : 6995 - 6999

[5] Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) : 4378 - 4386

[6] Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (02) : 497 - 506

[7] Regulation of angiogenesis by tissue factor cytoplasmic domain signaling [J]. NATURE MEDICINE, 2004, 10 (05) : 502 - 509

[8] The role of platelet adhesion receptor GPIbα far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (45) : 16900 - 16905

[9] INTERLEUKIN-1 (IL-1) INDUCES BIOSYNTHESIS AND CELL-SURFACE EXPRESSION OF PROCOAGULANT ACTIVITY IN HUMAN VASCULAR ENDOTHELIAL-CELLS [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) : 618 - 623

[10] The MET oncogene drives a genetic programme linking cancer to haemostasis [J]. NATURE, 2005, 434 (7031) : 396 - 400

[1] CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism [J]. NATURE MEDICINE, 2002, 8 (03) : 247 - 252

[2] Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis [J]. NATURE MEDICINE, 2001, 7 (02) : 215 - 221

[3] [Anonymous], 1986, Lancet, V1, P397

[4] EXPRESSION OF TISSUE FACTOR PROCOAGULANT ACTIVITY - REGULATION BY CYTOSOLIC CALCIUM [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) : 6995 - 6999

[5] Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) : 4378 - 4386

[6] Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (02) : 497 - 506

[7] Regulation of angiogenesis by tissue factor cytoplasmic domain signaling [J]. NATURE MEDICINE, 2004, 10 (05) : 502 - 509

[8] The role of platelet adhesion receptor GPIbα far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (45) : 16900 - 16905

[9] INTERLEUKIN-1 (IL-1) INDUCES BIOSYNTHESIS AND CELL-SURFACE EXPRESSION OF PROCOAGULANT ACTIVITY IN HUMAN VASCULAR ENDOTHELIAL-CELLS [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) : 618 - 623

[10] The MET oncogene drives a genetic programme linking cancer to haemostasis [J]. NATURE, 2005, 434 (7031) : 396 - 400